Expression of monocyte chemotactic protein-1 in human endometrial cancer cells and the effect of treatment with tamoxifen or buserelin

Journal of International Medical Research

Volumn 34, Issue 3, 2006, Pages 284-290

  Wang, L ^a   Zheng, W ^a   Zhang, S ^a   Chen, X ^a   Hornung, D ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Buserelin; Destrogen receptor modulator; Endometrial cancer; Gonadotrophin releasing hormone agonists; Monocyte chemotactic protein 1; Tamoxieen

Indexed keywords

BUSERELIN ACETATE; ESTROGEN RECEPTOR; GONADORELIN RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TAMOXIFEN;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STUDENT T TEST; WESTERN BLOTTING;

EID: 33745940094     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400307     Document Type: Article

References (15)

1. Davies S, Bax CM, Chatzaki E, Chard T, Iles RK: Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer 2000; 83: 1730-1734.
2. Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J: Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2001; 19: 364-367.
3. Brockbank EC, Ghaem-Maghami S, Bridges JE: The gynaecological management of women on tamoxifen: a national questionnaire survey. J Obstet Gynaecol 2004; 24: 675-679.
4. Goede V, Brogelli L, Ziche M, Augustin HG: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999; 82: 765-770.
5. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, et al: Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003; 22: 773-778.
6. Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube K, Uphoff CC (eds): DSMZ Catalogue Of Human And Animal Cell Lines, 7th edn. Braunschweig: DSMZ, 1999.
7. Zhang B, Chen D, Wang G, Wu Y: Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cells. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 283-285.
8. Arici A, Senturk LM, Seli E, Bahtiyar MO, Kim G: Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 1999; 61: 85-90.
9. Xie LP, Fu WX, Jin C, Dong XY, Chen WF: Negative regulation of monocyte chemoattractant protein-1 gene expression by a mouse estrogen-enhanced transcript. Eur J Immunol 2002; 32: 2837-2846.
10. Rodriguez E, Lopez R, Paez A, Masso F, Montano LF. 17β-estradiol inhibits the adhesion of leukocytes in TNF-α stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci 2002; 71: 2181-2193.
11. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000; 6: 3282-3289.
12. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, et al: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96: 34-40.
13. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K, et al: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001; 92: 1085-1091.
14. Kim JW, Lee YS, Kim BK, Park DC, Lee JM, Kim IK, et al: Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog. Gynecol Oncol 1999; 73: 368-371.
15. Cheng KW, Ngan ESW, Kang SK, Chow BKC, Leung PCK: Transcriptional down-regulation of human gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: role of protein kinase C and activating protein 1. Endocrinology 2000; 141: 3611-3622.